Health Care Weekly: Hims Defends Cancellation Policies; Comer Probes PBM Audits of Independent Pharmacies; Baxter Warned on Sterility Issues; Beta Bionics Pulls Application for Next-Gen Dosing Algorithm; FDA Targets ‘Gray or Black’ Peptide Market; CMS Eyes Premium Tax Credit Rule; Corcept, Genmab Tout Cancer Wins
The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week...
Oct 28, 2026
Read Now >

